Why is colon cancer survival improving by time? A nationwide survival analysis spanning 35 years-Reference-Cited by-同舟云学术

Why is colon cancer survival improving by time? A nationwide survival analysis spanning 35 years

Published:2017-05-19 Issue:3 Volume:141 Page:531-539
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Snaebjornsson Petur¹^ORCID,Jonasson Larus²³,Olafsdottir Elinborg J.⁴,van Grieken Nicole C.T.⁵,Moller Pall H.³⁶,Theodors Asgeir⁷,Jonsson Thorvaldur³⁶,Meijer Gerrit A.¹,Jonasson Jon G.²³⁴

Affiliation:

1. Department of Pathology; The Netherlands Cancer Institute-Antoni van Leeuwenhoek; Amsterdam The Netherlands

2. Department of Pathology; National University Hospital; Reykjavik Iceland

3. Faculty of Medicine; University of Iceland; Reykjavik Iceland

4. Icelandic Cancer Registry, Icelandic Cancer Society; Reykjavik Iceland

5. Department of Pathology; VU University Medical Center; Amsterdam The Netherlands

6. Department of Surgery; National University Hospital; Iceland

7. Department of Gastroenterology; National University Hospital; Iceland

Funder

Landspitali-University Hospital Research Fund

Memorial Fund of B. Magnusdottir and J. J. Bjarnason

Gastrointestinal Science Fund of Wyeth-Lederle

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ijc.30766/fullpdf

Reference35 articles.

1. Boyle P Levin B World Cancer Report 2008 2nd edn. Lyon IARCPRESS http://www.iarc.fr/en/publications/pdfs-online/wcr/2008/index.php

2. Progress in colorectal cancer survival in Europe from the late 1980s to the early 21st century: the EUROCARE study;Brenner;Int J Cancer,2012

3. Comparative cancer survival information in Europe;Berrino;Eur J Cancer,2009

4. An Icelandic example of the impact of population structure on association studies;Helgason;Nat Genet,2005

5. TNM Supplement

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapy in Stage III–IV Colon Cancer: A Propensity Score-Matched Analysis of the National Cancer Database;Journal of Immunotherapy;2024-04-18

2. The exploration of mitochondrial‐related features helps to reveal the prognosis and immunotherapy methods of colorectal cancer;Cancer Reports;2023-10-30

3. Construction and validation of a prognostic nomogram for predicting cancer-specific survival in patients with intermediate and advanced colon cancer after receiving surgery and chemotherapy;Journal of Cancer Research and Clinical Oncology;2023-07-17

4. Hsa_Circ_0104206 is An Oncogenic circRNA in Colon Cancer by Targeting Mir-188–3p/CCNA2 Axis;Hormone and Metabolic Research;2023-06-05

5. The E3 ubiquitin ligase SCF (FBXW10)-mediated LATS2 degradation regulates angiogenesis and liver metastasis in colorectal cancer;The International Journal of Biochemistry & Cell Biology;2023-05